Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor Majority of physicians and chronic neutropenia participants chose to significantly reduce G-CSF dosing when using mavorixafor in combination therapy BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced the acceptance of two abstracts for poster presentation at the ...

X4 Pharmaceuticals (XFOR) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Company Participants Dan Ferry - Managing DirectorPaula Ragan - Founder, President, CEO & Board MemberAdam Mostafa - CFOMark Baldry - Chief Commercial OfficerChristophe Arbet-Engels - Chief Medical OfficerStephen Willey - Managing Director Conference Call Participants Edward Tenthoff - Sr. Research AnalystSwayampakula Ramakanth - Managing Director & Senior Equity Analyst Operator Please stand by. Your program is about to begin. Greetin ...

X4 Pharmaceuticals (XFOR) Q4 2024 Earnings Call March 25, 2025 08:30 AM ET Company Participants Dan Ferry - Managing DirectorPaula Ragan - Founder, President & CEOAdam Mostafa - CFOChristophe Arbet-Engels - Chief Medical OfficerMark Baldry - Chief Commercial OfficerAyan Hussein - Equity Research AssociateDouglas Macpherson - Equity Research Associate Conference Call Participants Stephen Willey - AnalystDavid Bautz - Senior Analyst Operator Greetings and welcome to the X4 Pharmaceuticals Fourth Quarter and F ...

X4 Pharmaceuticals (XFOR) Q4 2024 Earnings Call March 25, 2025 08:30 AM ET Company Participants Dan Ferry - Managing DirectorPaula Ragan - Founder, President & CEOAdam Mostafa - CFOChristophe Arbet-Engels - Chief Medical OfficerMark Baldry - Chief Commercial OfficerAyan Hussein - Equity Research AssociateDouglas Macpherson - Equity Research Associate Conference Call Participants Stephen Willey - AnalystDavid Bautz - Senior Analyst Operator Greetings and welcome to the X4 Pharmaceuticals Fourth Quarter and F ...